Answers are grounded in this paper and cite their sources.
COVID-19 is without a doubt the most extensively researched infectious disease in history, with over 130,000 PubMed and NCBI citations between January 2020 and September 2023. This compares to around 8,000 citations for influenza and 10,000 citations for tuberculosis during the same period. The value of molecular diagnostics in COVID-19 assessment in terms of lowering morbidity and death is widely acknowledged. This review assesses the impact of COVID-19 on the development of detection methods and emphasizes the specificity and sensitivity of PCR testing.
No takes yet. Share an insight, caveat, or question.
Husein Djedović (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: